Drug Profile
DB 772d
Alternative Names: DB-772dLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Daiichi Sankyo Company
- Class
- Mechanism of Action Factor Xa inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cardiovascular disorders
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for phase-I development in Cardiovascular-disorders in European Union (PO)
- 16 Jul 2016 No recent reports of development identified for phase-I development in Cardiovascular-disorders in USA (PO)
- 31 Jan 2008 Phase-I clinical trials in Cardiovascular disorders in USA (PO)